Skip to main content
Premium Trial:

Request an Annual Quote

Cellectis Bioresearch Establishes US Subsidiary

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellectis bioresearch today announced it has created a US subsidiary.

The US subsidiary is called Cellectis bioresearch Inc., and is headquartered at the Cambridge Innovation Center in Cambridge, Mass. Cellectis bioresearch, based in Romainville, France, is a subsidiary of Cellectis, and provides tools for genome customization.

The US company will be responsible for promoting Cellectis bioresearch products and services in the US. Eric Merle has been named sales director for the US and will be in charge of recruiting and managing a sales staff. He will report to Luc Selig, vice president of sales and marketing at the French operations.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.